Apple has told participants in its heart study that their data will be used to seek FDA approval for an investigational device.
Researchers say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of cognitive skills in Alzheimer’s patients.
The careful optimization of tumor-bearing humanized models leads to highly useful preclinical immuno-oncology platforms for accelerated immunotherapy…
Paris-based SafeHeal has begun a CE mark study for its Colovac device that is designed to be used as a bypass after a rectal resection.
The platform will use a narrow, intense X-ray beam produced at a particle accelerator to perform the structural analysis.
Roche launched a new test to detect sexually transmitted infections as part of its cobas 6800/8800 systems in markets accepting the CE mark.
Researchers at Johns Hopkins have developed a noninvasive blood test that can detect signs of eight different types of cancer before symptoms begin.
The expansion will entail validating the use of the tumor microenvironment tests in new indications while setting up a lab in the U.S.
Illumina, the maker of DNA sequencers, unveiled its latest device with a price tag of just under $20,000.
The project will see Regeneron sequence the exomes of 500,000 Britons with the financial backing of AbbVie, Alnylam, AstraZeneca, Biogen and Pfizer.
AstraZeneca and Myriad Genetics are partnering to identify women with advanced ovarian cancer who might benefit from treatments using Lynparza and Avastin as…